Nathan C. Bahr

4.7k citations

86 papers · 2.1k indexed · h-index 24

Infectious Diseases top 1%
- Antifungal resistance and susceptibility 47
- Tuberculosis Research and Epidemiology 8
Microbiology top 1%
- Bacterial Infections and Vaccines 18
Epidemiology top 2%
- Fungal Infections and Studies 48
- Pneumocystis jirovecii pneumonia detection and treatment 17
- Nail Diseases and Treatments 15
Microbiology top 5%
- Bacterial Infections and Vaccines 18
Small Animals top 5%
Surgery
- Infectious Diseases and Tuberculosis 22
- Orthopedic Infections and Treatments 7

Co-authors: David R. Boulware L. Joseph Wheat Chadi A. Hage Marwan M. Azar David B. Meya Joshua Rhein George A. Sarosi Victoria Poplin
Cited by: Infectious Diseases Microbiology Epidemiology
Journals: SHILAP Revista de lepidopterología (2 papers)Clinical Infectious Diseases (12 papers)Journal of Clinical Microbiology (2 papers)
Partner nations: United States Uganda United Kingdom

In The Last Decade

Nathan C. Bahr

80 papers receiving 2.1k citations

Peers

Countries citing papers authored by Nathan C. Bahr

Since Specialization

Citations

This map shows the geographic impact of Nathan C. Bahr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan C. Bahr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan C. Bahr more than expected).

Fields of papers citing papers by Nathan C. Bahr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan C. Bahr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan C. Bahr. The network helps show where Nathan C. Bahr may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nathan C. Bahr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nathan C. Bahr Line = papers co-authored together Nathan C. Bahr links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prognostic Value of C-Reactive Protein in Adults With Tuberculous Meningitis: A Prospective Cohort Study Clinical Infectious Diseases ·Lillian Tugume,Fiona V Cresswell,Nicole Engen,Asmus Tukundane,Sarah Kimuda,Timothy Mugabi,Suzan Namombwe,Enock Kagimu,Mable Kabahubya,Jayne Ellis,Nathan C. Bahr,David B. Meya,David R. Boulware	2025	0
2	Persistent fever after coronavirus disease 2019 in liver/kidney transplant recipient Transplant Infectious Disease ·Caroline E. Mullis,Madeleine R. Heldman,Nathan C. Bahr,Grace Y. Minamoto,Yoram A. Puius,Maricar Malinis	2024	0
3	Infectious Diseases Physician Management of Cryptococcal Meningitis in North America—Is Single High-Dose Liposomal Amphotericin B Being Used? Open Forum Infectious Diseases ·Nathan C. Bahr,Susan E. Beekmann,Philip M. Polgreen,Jeremey Walker,Andrej Spec,David R. Boulware,John W. Baddley	2024	4
4	Geographical distribution of the Cryptococcus gattii species complex: a systematic review The Lancet Microbe ·Victoria Poplin,Clarissa Smith,Diego H. Cáceres,Patrícia Fernanda Herkert,Olujimi Jegede,George R. Thompson,John W. Baddley,Ilan S. Schwartz,R Kubát,Mark A. Deka,Mitsuru Toda,Shawn R. Lockhart,Tom Chiller,Ferry Hagen,Nathan C. Bahr	2024	5
5	Diagnostic accuracy of a novel lateral flow assay for histoplasmosis Medical Mycology ·Megan Burrows,J. D. Miller,Rachael M. Liesman,Nathan C. Bahr	2024	2
6	Low incidence of invasive fungal infections in a large observational cohort of patients initiating IL-17 or IL-23 inhibitor therapy, United States, 2016-2022 Journal of the American Academy of Dermatology ·Nathan C. Bahr,Kaitlin Benedict,Mitsuru Toda,Jeremy A.W. Gold,Shari R. Lipner	2024	3
7	Advancing Diagnosis and Treatment in People Living with HIV and Tuberculosis Meningitis Current HIV/AIDS Reports ·Sarah Kimuda,Derrick Kasozi,Suzan Namombwe,Jane Gakuru,Timothy Mugabi,Enock Kagimu,Morris K Rutakingirwa,Kristoffer E. Leon,Felicia C. Chow,Sean Wasserman,David R. Boulware,Fiona V Cresswell,Nathan C. Bahr	2023	2
8	Prevalence of Histoplasma Antigenuria among Outpatient Cohort with Advanced HIV in Kampala, Uganda Journal of Fungi ·Preethiya Sekar,Elizabeth Nalintya,Richard Kwizera,Claudine Mukashyaka,Godfrey Niyonzima,Loryndah Olive Namakula,Patricia Nerima,Ann Fieberg,Biyue Dai,Jayne Ellis,David R. Boulware,David B. Meya,Nathan C. Bahr,Radha Rajasingham	2023	4
9	Advanced HIV disease: A review of diagnostic and prophylactic strategies HIV Medicine ·Alice Lehman,Jayne Ellis,Elizabeth Nalintya,Nathan C. Bahr,Angela Loyse,Radha Rajasingham	2023	12
10	Pregnancy-Related Tuberculous Meningitis and Immune Reconstitution Inflammatory Syndrome: A Case Series and Systematic Review Open Forum Infectious Diseases ·Katelyn A Pastick,Enock Kagimu,Joanna Dobbin,Kenneth Ssebambulidde,Jane Gakuru,Jack Milln,Betty Nakabuye,David B. Meya,David R. Boulware,Fiona V Cresswell,Nathan C. Bahr	2022	4
11	Evaluation of the Diagnostic Accuracy and Clinical Utility of Fungal Profile Plus Polymerase Chain Reaction Assay in Pulmonary Infections Open Forum Infectious Diseases ·Clarissa B. Smith,Xiaosong Shi,Rachael M. Liesman,Laura A. Thomas,Nathan C. Bahr,Kyle R. Brownback	2022	7
12	Management of Histoplasmosis by Infectious Disease Physicians Open Forum Infectious Diseases ·Patrick B Mazi,Sandra R. Arnold,John W. Baddley,Nathan C. Bahr,Susan E. Beekmann,Todd P McCarty,Philip M. Polgreen,Adriana M. Rauseo,Andrej Spec	2022	14
13	Diagnosis of Pulmonary Infections Due to Endemic Fungi Diagnostics ·Victoria Poplin,Clarissa B. Smith,Dominique Milsap,Lauren Zabel,Nathan C. Bahr	2021	11
14	A clinical review of human disease due to Paragonimus kellicotti in North America Parasitology ·Brianna Coogle,Samuel Sosland,Nathan C. Bahr	2021	6
15	Tuberculosis IRIS: Pathogenesis, Presentation, and Management across the Spectrum of Disease Life ·Carson Quinn,Victoria Poplin,John Kasibante,Kyle Yuquimpo,Jane Gakuru,Fiona V Cresswell,Nathan C. Bahr	2020	43
16	Clinical characteristics, laboratory findings, radiographic signs and outcomes of 61,742 patients with confirmed COVID-19 infection: A systematic review and meta-analysis Microbial Pathogenesis ·Ali Pormohammad,Saeed Ghorbani,Behzad Baradaran,Alireza Khatam,Raymond Turner,Mohammad Alì Mansournia,Demetrios Kyriacou,Juan‐Pablo Idrovo,Nathan C. Bahr	2020	12
17	Cryptococcal meningitis is a cause for cross‐reactivity in cerebrospinal fluid assays for anti‐Histoplasma, anti‐Coccidioides and anti‐Blastomyces antibodies Mycoses ·Nathan C. Bahr,Anil A. Panackal,Michelle Durkin,Melinda Smedema,Wesley Keown,Thomas E. Davis,Luke Raymond‐Guillen,Yoon‐Dong Park,Kieren A. Marr,Bettina C. Fries,Peter R. Williamson,David R. Boulware,L. Joseph Wheat	2018	6
18	Reproducibility of CSF quantitative culture methods for estimating rate of clearance in cryptococcal meningitis Medical Mycology ·Jonathan Dyal,Andrew Akampurira,Joshua Rhein,Bożena M Morawski,Reuben Kiggundu,Henry W. Nabeta,Abdu K Musubire,Nathan C. Bahr,Darlisha A Williams,Tihana Bicanic,Robert A. Larsen,David B. Meya,David R. Boulware,(unknown)	2016	32
19	Histoplasmosis Infections Worldwide: Thinking Outside of the Ohio River Valley Current Tropical Medicine Reports ·Nathan C. Bahr,Spinello Antinori,L. Joseph Wheat,George A. Sarosi	2015	158
20	Unmasking cryptococcal meningitis immune reconstitution inflammatory syndrome in pregnancy induced by HIV antiretroviral therapy with postpartum paradoxical exacerbation Medical Mycology Case Reports ·Reuben Kiggundu,Joshua Rhein,David B. Meya,David R. Boulware,Nathan C. Bahr	2014	13

About Nathan C. Bahr

Nathan C. Bahr is a scholar working on Microbiology, Infectious Diseases and Microbiology, having authored 86 papers that have together received 2.1k indexed citations. Recurring topics across this work include Fungal Infections and Studies (48 papers), Antifungal resistance and susceptibility (47 papers), Infectious Diseases and Tuberculosis (22 papers), Bacterial Infections and Vaccines (18 papers), Pneumocystis jirovecii pneumonia detection and treatment (17 papers), Nail Diseases and Treatments (15 papers), Tuberculosis Research and Epidemiology (8 papers) and Orthopedic Infections and Treatments (7 papers). The work is most often cited by research in Infectious Diseases (1.5k citations), Microbiology (375 citations) and Epidemiology (1.5k citations). Nathan C. Bahr has collaborated with scholars based in United States, Uganda and United Kingdom. Frequent co-authors include David R. Boulware, L. Joseph Wheat, Chadi A. Hage, Marwan M. Azar, David B. Meya, Joshua Rhein, George A. Sarosi, Victoria Poplin, Andrej Spec and Spinello Antinori. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Journal of Clinical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact